Abstract
Cervical cancer is the principal cause of cancer-related mortality and is a major reproductive health problem in Indian women. Despite the successful development of vaccines against its causative agent (human papillomavirus [HPV]), which could be used as primary prevention tool, the highly beneficial effects of cervical screening by visual inspection with acetic acid, cytology and recently HPV DNA detection, and advances in technologies for detection of incipient lesions and HPV infection, the problem of cervical cancer is still prevalent in the country. This article reviews the status of HPV and the epidemiology of the major disease that it causes in India with various opportunities, obstacles and efforts to overcome the roadblocks for the control of cervical cancer in resource-limited settings such as India.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
Notes
HPV: Human papillomavirus.
HPV: Human papillomavirus.
HPV: Human papillomavirus.